Physical Therapy with Transfer of Energy Capacitive and Resistive (TECAR) radiofrequency therapy for multimodal care of Hypersensitivity Pneumonitis: A case report

能量传递电容电阻式(TECAR)射频疗法联合物理疗法治疗过敏性肺炎的多模式治疗:病例报告

阅读:1

Abstract

INTRODUCTION: Hypersensitivity pneumonitis (HP) is an exposure-related interstitial lung disease that may progress to pulmonary fibrosis, resulting in impaired gas exchange, dyspnea, and reduced functional capacity. Pulmonary rehabilitation is an established supportive intervention in interstitial lung disease; however, evidence for adjunct biophysical modalities such as Transfer of Energy Capacitive and Resistive (TECAR) radiofrequency therapy in HP is lacking. METHODS: A 61-year-old female with hypersensitivity pneumonitis from domestic mold exposure completed an 8-week rehabilitation program (11 sessions) incorporating Transfer of Energy Capacitive and Resistive therapy, manual therapy, and breathing-based exercise. Each 30-45min. session applied capacitive and resistive energy transfer to thoracic structures to promote tissue mobility and respiratory efficiency. RESULTS: Post-intervention pulmonary function tests showed increases in forced vital capacity (FVC +5%), total lung capacity (TLC +12%), diffusion capacity for carbon monoxide (DLCO +22%), and residual volume (RV +39%). The patient reported reduced dyspnea, improved walking tolerance from <5 to >20 minutes, and independence in stair climbing and balance tasks. No adverse effects occurred. Observed pulmonary function changes were interpreted cautiously given known biological and technical variability, particularly for diffusion and lung volume measures. CONCLUSIONS: This case demonstrates the feasibility of integrating TECAR therapy within a comprehensive pulmonary rehabilitation program for fibrotic hypersensitivity pneumonitis, with concurrent functional gains and selected pulmonary function improvements. Findings are hypothesis-generating and cannot be attributed specifically to TECAR therapy. Controlled studies are needed to evaluate efficacy, mechanisms, and clinical relevance of TECAR-assisted rehabilitation in HP and other interstitial lung diseases.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。